Related Experiment Video
Updated: Jan 13, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
Integrated Alcohol Use Disorder and Liver Disease Management
Hanna Blaney1, Adelina Horhat2, Abdulmalik Saleem3
1Medstar Transplant Hepatology Institute, MedStar Georgetown University Hospital, Washington, District of Columbia.
Integrated care for alcohol-associated liver disease (ALD) and alcohol use disorder (AUD) improves patient outcomes. This multidisciplinary approach is feasible and effective for managing these dual conditions.
Area of Science:
- Hepatology
- Addiction Medicine
- Public Health
Background:
- Alcohol-associated liver disease (ALD) is a major global health issue linked to hazardous alcohol consumption.
- Alcohol use disorder (AUD) frequently co-occurs with ALD, complicating patient management.
- Current treatment rates for AUD in ALD patients remain low, highlighting a significant care gap.
Purpose of the Study:
- To review the epidemiology, diagnosis, and treatment of AUD and ALD.
- To examine successful integrated care models for co-occurring AUD and ALD.
- To identify knowledge gaps and future research directions in managing these conditions.
Main Methods:
- Literature review of AUD and ALD epidemiology, diagnosis, and treatment.
- Analysis of integrated care models involving hepatologists and AUD specialists.
- Discussion of research needs, including peri-transplantation care and harm reduction.
Main Results:
- Integrated care models show promise in reducing alcohol relapse, healthcare utilization, and improving mortality.
- Multidisciplinary care is essential for addressing the dual pathologies of AUD and ALD.
- Successful integrated care demonstrates feasibility and effectiveness.
Conclusions:
- Integrated care for AUD and ALD is effective and feasible.
- Addressing AUD is crucial for comprehensive ALD management.
- Future research should focus on expanding integrated care, harm reduction, and peri-transplantation support.
More Related Videos
07:31Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
Published on: January 7, 2019
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Pancreatitis II: Collaborative Care
Assessment:
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Myocarditis IV: Nursing Management